InnaVirVax and piCHEM agree cooperation on the development of a synthetic therapeutic vaccine candidate for HIV-infection.

InnaVirVax SA (www.innavirvax.fr), a privately-owned biopharmaceutical company located in the Paris Region biopark of Evry, France is dedicated to the development of a cutting edge discovery in the field of therapy/prevention and prognosis of AIDS and HIV infection and new cancer therapies.

piCHEM provides its extensive know-how in the development and production of peptide based active pharmaceutical ingredients for the development of new and innovative drugs.

The agreed cooperation is another important step for piCHEM to broaden its competency in the development and production of vaccines.

piCHEM is very proud to be involved in the fight against HIV/AIDS!

Birgit Primus is our newest chemical lab technician. Birgit has passed her apprenticeship with excellence in 2006 and has been working for the last 3 years in the field of development and manufacturing of coatings, paint, and wood preservatives.

At piCHEM she will assist the peptide production and purification.

Welcome to piCHEM!

piCHEM exhibited at the CPhI/ ICSE worldwide 2009 in Madrid from October 13 to 15.

piCHEM presented its innovative products and services at the CPhI/ICSE, the world´s largest pharmaceutical exhibition. The total attendance of the event was over 25,450 people. piCHEM was one of the 1,808 exhibitors. This event represented a unique platform to meet our global clientele and keep up to date with the latest industry trends, ensuring that we gain a competitive edge in an evolving global market. The 2010 expo will take place in Paris Nord Villepinte, France from October 5 to 7.

ICSE - International Contract Services Expo

We were successfully audited in January 2009 and have received our new GMP certificate from the Austrian authorities!

Please download our new certificate!